agonistaheadaiaimsanalystannouncedapproachapprovalascoasgctashautoimmunebasedbehindbelievesbetterbiobiopharmabiosciencesbiotechbrainbreastbrianbuildingbuiltcambridgecancercatalystscellcellsceochairmanclinicalcocombinationcompaniescompanyconditionsconferencecoverscurrentdatadaviddaydegradationdelivereddescribesdesigndesigneddevelopdevelopingdevelopmentdirectordiscoverydiscussdiscussesdiseasediseasesdrugearlierearlyeditingenvironmenteuropeexpertiseexplainsfdafieldfirmfirstfocusedfounderfrontfundfuturegenegenerationgetglobalheadhealthhealthcarehelphighlightsincludingindustryinhibitorinnovationinternationalinvestmentinvestorjefferiesjohnjoneskeykidneylastlatelatestlaunchedleadleveraginglifelondonmedicinemedicinesmicrobiomemillionmoleculemonthmultiplenextnowobesityoncologyoraloxfordparetopartnerpatientspaulpharmaphasepipelinepivotalplatformpossiblepresentedpreviewsprogramprogramsproteinraiseraisedrarerbcreadrecentrecentlyreceptorresearchresultsrightscheduledsciencesciencesscotlandsectorsecuritiesseniorseriessfsharesshowingsmallspacestagestatestifelstudysummitswisssyndrometaketalkstargettargetingtargetstechnologytherapeuticstherapiestherapythoughtsthreetodaytoptourtreatmenttrialtrialstumortypeukuniqueuniversityupcomingupdateupdatesususeusesusingvaccineviawalksweekwillworkworkingyear